XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
  Asthma
  COPD
  Cystic Fibrosis
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

COPD Channel
subscribe to COPD newsletter

Latest Research : Respiratory Medicine : COPD

   DISCUSS   |   EMAIL   |   PRINT
Lung function test underused in patients with COPD
Jun 14, 2006, 20:14, Reviewed by: Dr. Priya Saxena

"Symptoms of COPD may not be noticeable for several years, making it difficult to diagnose and treat the disease in its early stages. Lung function testing for smokers and other high-risk patients may help with early identification of COPD and more effective disease management."

 
At least two thirds of patients with chronic obstructive pulmonary disease (COPD) do not receive lung function testing that is recommended for the accurate diagnosis and effective management of the disease, suggesting that the majority of patients are diagnosed with COPD based on symptoms alone. New research published in the June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP), finds that only one third of patients recently diagnosed with COPD underwent spirometry, a noninvasive lung function test, to confirm COPD or to manage their condition. Current national guidelines recommend spirometry for the diagnosis and management of COPD.

"Spirometry testing is necessary for the diagnosis and staging of COPD, yet the majority of patients with COPD are being diagnosed based on symptoms and smoking history," Todd A. Lee, PharmD, PhD, Hines VA Hospital, Hines, IL, Northwestern University Feinberg School of Medicine, Chicago, IL. "While these patients may indeed have COPD, spirometry is needed to make a definite diagnosis. As a result, patients who do not have COPD may be receiving unnecessary chronic therapy."

Lee and colleagues examined the use of spirometry among 197,878 patients (98 percent men) from the Veterans Health Administration (VHA) health-care system who were newly diagnosed with COPD. Patient records were reviewed for the general use of spirometry and spirometry related to exacerbation or surgery over a 12-month period. Of the patients, 33.7 percent had at least one spirometry through the VHA over the course of a year. A random sample of 6,000 patients revealed an additional 4.3 percent of patients underwent spirometry in non-VHA settings. Among patients who experienced acute exacerbation of COPD, spirometry was performed only 21.4 percent of the time, despite current guidelines that recommend spirometry four to six weeks after an exacerbation. Spirometry was used most frequently around surgical procedures that required general anesthesia, with 85.5 percent of patients having spirometry performed 30 days or less before their procedure.

A pulmonary clinic visit was the factor that had the highest association with having a spirometry test. Patients seen by a pulmonologist were three times more likely to have a spirometry test than those with no pulmonary visit. Younger age was significantly associated with the likelihood of having spirometry performed. Compared to patients younger than 50 years old, the likelihood of having a spirometry performed was 18 percent lower in those 60-69 years, 32 percent lower in those 70-79 years, and 48 percent lower in those 80 years or older. In addition, mental health and substance abuse diagnosis were also associated with lower likelihood of having spirometry performed.

"Providers may be more reluctant to use spirometry in older patients because of concerns about the validity and acceptability of the test results," said Dr. Lee. "Providers also may be interested in a definitive diagnosis for younger patients that are experiencing symptoms associated with COPD and thus refer these patients for spirometry." Although the role of spirometry in routine clinical practice remains unclear, researchers believe there is a need to increase the training and use of lung function testing in the primary care setting.

"COPD is a highly preventable disease most commonly caused by long-term smoking," said W. Michael Alberts, MD, FCCP, President of the American College of Chest Physicians. "Symptoms of COPD may not be noticeable for several years, making it difficult to diagnose and treat the disease in its early stages. Lung function testing for smokers and other high-risk patients may help with early identification of COPD and more effective disease management."
 

- June issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians (ACCP)
 

www.chestnet.org

 
Subscribe to COPD Newsletter
E-mail Address:

 

CHEST is a peer-reviewed journal published by the ACCP. It is available online each month at www.chestjournal.org. The ACCP represents 16,500 members who provide clinical respiratory, sleep, critical care, and cardiothoracic patient care in the United States and throughout the world. The ACCP's mission is to promote the prevention and treatment of diseases of the chest through leadership, education, research, and communication. For more information about the ACCP, please visit the ACCP Web site at www.chestnet.org.

Related COPD News

COPD patients using beta-agonist inhalers are at risk
Beta-agonists more than double death rate in COPD patients
Lung function test underused in patients with COPD
Wrinkles clue to risk of progressive lung disease (COPD)
Antibiotics reduce risk of dying from COPD attack by 77 percent
Women with chronic obstructive pulmonary disease (COPD) fare worse than men
Breathing Heliox 28 significantly improve the exercise performance in COPD
Combined treatment cuts inflammatory cells in chronic obstructive pulmonary disease
COPD is slated to become world's biggest killer by 2020 - WHO
Study Shows Benefits of Inhaled Corticosteroids in Chronic Obstructive Pulmonary Disease


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us